Westmead Institute for Medical Research at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Westmead Institute for Medical Research brings 2 presentations to ESGCT 2026 in Hamburg. Its work covers AAV gene therapy for the heart. One line uses slices of human heart tissue to find new AAV vectors that reach cardiac cells, and another tests AAV-delivered treatment in a preclinical model of cardiac arrhythmia.
| Organization | ESGCT 2026 Attendance |
|---|---|
Westmead Institute for Medical Research Sydney, Australia | |
Poster Wed Oct 28 1:30pm–3:30pm Human cardiac slices as a translational model for the discovery of novel recombinant adeno-associated viral (rAAV) vectors in cardiac gene therapy Poster Thu Oct 29 2:00pm–4:00pm Novel approaches for recombinant AAV-mediated gene therapy in a pre-clinical model of cardiac arrhythmia |
Instantly find 20 buyers from Westmead Institute for Medical Research
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction